natgillin/translations-raw huggingface dataset:
Pharmacotherapeutic group: Anticholinergics; ATC Code: R03BB05.
Farmakoterapijska skupina: Antikolinergici; ATK oznaka: R03BB05.
Pharmacotherapeutic group: Antidotes, ATC code: V03AB33 Mechanism of action
Farmakoterapijska skupina: protuotrovi, ATK oznaka: V03AB33 Mehanizam djelovanja
Pharmacotherapeutic group: Antiemetics and antinauseants, ATC code: A04AD12.
Farmakoterapijska skupina: Antiemetici i pripravci za suzbijanje mučnine, ATK oznaka: A04A D12
Pharmacotherapeutic group: Antiemetics and antinauseants, serotonin (5-HT3) antagonists; ATC code: A04AA55
Farmakoterapijska skupina: Antiemetici i lijekovi protiv mučnine, antagonisti serotonina (5-HT3) ATK oznaka: A04AA55
Pharmacotherapeutic group: Antiemetics and antinauseants, serotonin (5HT3) antagonists ATC code: A04AA02
Farmakoterapijska skupina: Antiemetici i sredstva protiv mučnine, antagonisti serotonina (5HT3) ATK oznaka: A04AA02
Pharmacotherapeutic group: Antiemetics and antinauseants, Serotonin (5HT3) antagonists, ATC code: A04AA05
Farmakoterapijska skupina: Antiemetici i sredstva protiv mučnine, antagonisti serotonina (5HT3), ATK oznaka: A04AA05.
Pharmacotherapeutic group: Antiemetics and antinauseants, serotonin (5HT3) antagonists.
Farmakoterapijska skupina: Antiemetici i sredstva protiv mučnine, antagonisti serotonina (5HT3).
Pharmacotherapeutic group: Antiepileptics Other antiepileptics imepitoin ATCvet code: QN03AX90
Farmakoterapijska grupa: antiepileptici, drugi antiepileptici imepitoin ATCvet kod: QN03AX90
Pharmacotherapeutic group: antiepileptics, other antiepileptics, ATC code: N03AX23 Mechanism of action
Farmakoterapijska skupina: antiepileptici, ostali antiepileptici; ATK oznaka: N03AX23 Mehanizam djelovanja
Pharmacotherapeutic Group: Antiglaucoma preparations and miotics, carbonic anhydrase inhibitors, ATC code: S01EC04
Farmakoterapijska skupina: lijekovi za liječenje glaukoma i miotici, inhibitori karboanhidraze, ATK oznaka: S01EC04
Pharmacotherapeutic group: Antihaemorrhagic, blood coagulation factor IX; ATC code: B02BD09 Mechanism of action
Farmakoterapijska skupina: antihemoragici, faktor zgrušavanja krvi IX; ATK oznaka: B02BD09 Mehanizam djelovanja
Pharmacotherapeutic group: Antihaemorrhagics Blood Coagulation factor XIII, ATC code: B02BD11.
Farmakoterapijska skupina: Antihemoragici, faktor zgrušavanja krvi XIII, ATK oznaka: B02BD11.
Pharmacotherapeutic group: antihaemorrhagics, blood coagulation factor IX, ATC code: B02BD04 Mechanism of action
Farmakoterapijska skupina: antihemoragici, faktor zgrušavanja krvi IX, ATK oznaka: B02BD04 Mehanizam djelovanja
Pharmacotherapeutic group: antihaemorrhagics, blood coagulation factor IX.
Farmakoterapijska skupina: antihemoragici, faktor zgrušavanja krvi IX.
Pharmacotherapeutic group: antihaemorrhagics, blood coagulation factor VIII, ATC code: B02BD02 Mechanism of action
Farmakoterapijska skupina: antihemoragici, faktor zgrušavanja krvi VIII, ATK oznaka: B02BD02 Mehanizam djelovanja
Pharmacotherapeutic group: Antihaemorrhagics, other systemic hemostatics, ATC code: B02BX04 Mechanism of action
Farmakoterapijska skupina: antihemoragici, ostali sistemski hemostatici, ATK oznaka: B02BX04 Mehanizam djelovanja
Pharmacotherapeutic group: Antihaemorrhagics: Blood coagulation factor IX.
Farmakoterapijska skupina: Antihemoragici: Koagulacijski faktor IX.
Pharmacotherapeutic group: Antihaemorrhagics: Blood coagulation factors, von Willebrand factor and coagulation factor VIII in combination.
Farmakoterapijska skupina: antihemoragici: faktori zgrušavanja krvi, kombinacija von Willebrandova faktora i koagulacijskog faktora VIII.
Pharmacotherapeutic group: antihemorrhagics, blood coagulation factor VIII, ATC code: not yet assigned.
Farmakoterapijska skupina: antihemoragici, krvni koagulacijski faktor VIII, ATK oznaka: B02BD02.
Pharmacotherapeutic group: antihemorrhagics: blood coagulation factor VIII, ATC code: B02BD02 Mechanism of action
Farmakoterapijska skupina: antihemoragici: krvni koagulacijski faktor VIII, ATK oznaka: B02BD02 Mehanizam djelovanja
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27 Mechanism of action
Farmakoterapijska skupina: antihistaminici – antagonist H1-receptora, ATK oznaka: R06A X27 Mehanizam djelovanja
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27 Mechanism of action
Farmakoterapijska skupina: antihistaminici – H1 antagonisti, ATK oznaka: R06A X27 Mehanizam djelovanja
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27 Mechanism of action
Farmakoterapijska skupina: Ostali antihistaminici za sustavnu primjenu, ATK oznaka: R06AX27 Mehanizam djelovanja
Pharmacotherapeutic group: Antihypertensives for pulmonary arterial hypertension, ATC code: C02KX05
Farmakoterapijska skupina: antihipertenzivi za plućnu arterijsku hipertenziju, ATK oznaka: C02KX05
Pharmacotherapeutic group: Antiinfectives for systemic use, pleuromutilins.
Farmakoterapijska grupa: Antiinfektivi za sustavnu primjenu, pleuromutilini.
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non steroids.
Farmakoterapijska grupa: Nesteroidni protuupalni i antireumatski pripravci.
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet Code: QM01AC06
Farmakoterapijska skupina: nesteroidni protuupalni i antireumatski lijekovi (oksikami) ATKvet oznaka: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06.
Farmakoterapijska skupina: protuupalni i protureumatski proizvodi, nesteroidi (oksikami) ATKvet kod: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams).
Farmakoterapijska grupa: protuupalni i protureumatski proizvodi, nesteroidi (oksikami)
Pharmacotherapeutic group: Antimetabolites, pyrimidine analogues, ATC code: L01BC01 Mechanism of action
Farmakoterapijska skupina: Antimetaboliti, analozi pirimidina, ATK oznaka: L01BC01 Mehanizam djelovanja
Pharmacotherapeutic group: antimycotics for systemic use, ATC Code: J02AX04 Mechanism of action
Farmakoterapijska skupina: antimikotici za sistemsku primjenu, ATK oznaka: J02AX04 Mehanizam djelovanja
Pharmacotherapeutic group: antineoplastic agent protein kinase inhibitor, ATC code: L01XE03 Mechanism of action
Farmakoterapijska skupina: antineoplastični lijekovi; inhibitor protein kinaze, ATK oznaka: L01XE03 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agent, other antineoplastic agents, monoclonal antibodies, ATC code: L01XC14
Farmakoterapijska skupina: Antineoplastici; ostali antineoplastici; monoklonska protutijela, ATK oznaka: L01XC14
Pharmacotherapeutic group: Antineoplastic agent, other antineoplastic agents, protein kinase inhibitor, ATC code: L01XE07
Farmakoterapijska skupina: antineoplastični lijekovi, ostali neoplastični lijekovi, inhibitori protein kinaze, ATK oznaka: L01XE07
Pharmacotherapeutic Group: antineoplastic agent, protein kinase inhibitor, ATC Code: L01XE12 Mechanism of action and pharmacodynamic effects
Farmakoterapijska skupina: antineoplastici, inhibitori protein-kinaze, ATK oznaka: L01XE12 Mehanizam djelovanja i farmakodinamički učinci
Pharmacotherapeutic group: antineoplastic agent, protein kinase inhibitor, ATC code: L01XE24
Farmakoterapijska skupina: antineoplastična tvar, inhibitor protein kinaze, ATK oznaka: L01XE24
Pharmacotherapeutic group: Antineoplastic agent, Sensitizers used in photodynamic/radiation therapy, ATC code: L01XD04
Farmakoterapijska skupina: antineoplastična tvar, senzibilizatori za fotodinamsku/radijacijsku terapiju, ATK oznaka: L01XD04
Pharmacotherapeutic group: Antineoplastic Agents – Protein-kinase inhibitors ATC vet code: QL01XE91
Farmakoterapijska grupa: antineoplastične tvari –inibitori protein-kinaze ATCvet kod: QL01XE91
Pharmacotherapeutic group: Antineoplastic agents, Alkylating Agents, ATC code: L01AC01 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, alkilirajući pripravci, ATK oznaka: L01AC01 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, anthracyclines, and related substances.
Farmakoterapijska skupina: Antineoplastik (citostatik), antraciklini, i srodne tvari.
Pharmacotherapeutic group: antineoplastic agents, antimetabolites, ATC code: L01BC06.
Farmakoterapijska skupina: antineoplastik, antimetabolit, ATK oznaka: L01BC06
Pharmacotherapeutic group: antineoplastic agents, antimetabolites, ATC code: L01BC59 Mechanism of action
Farmakoterapijska skupina: antineoplastici, antimetaboliti, ATK oznaka: L01BC59 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, folic acid analogues.
Farmakoterapijska skupina: antineoplastici, antimetaboliti, analozi folatne kiseline.
Pharmacotherapeutic group: antineoplastic agents, antimetabolites, pyrimidine analogues, ATC code: L01BC06
Farmakoterapijska skupina: antineoplastici (antimetabolici), pirimidinski analozi, ATK oznaka: L01BC06
Pharmacotherapeutic group: Antineoplastic agents, ATC code: L01XE38 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, ATK oznaka: L01XE38 Mehanizam djelovanja
Pharmacotherapeutic group: antineoplastic agents, folic acid analogues, ATC code: L01BA04.
Farmakoterapijska skupina: antineoplastici, analozi folatne kiseline, ATK oznaka: L01BA04
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC06 Mechanism of action
Farmakoterapijska skupina: antineoplastici, monoklonska protutijela, ATK oznaka: L01XC06 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC08 Mechanism of action
Farmakoterapijska skupina: antineoplastici, monoklonska protutijela, ATK oznaka: L01XC08 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC09 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, monoklonska protutijela, ATK oznaka: L01XC09 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC13 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, monoklonska protutijela, ATK oznaka: L01XC13 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC15 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, monoklonska protutijela, ATK oznaka: L01XC15 Mehanizam djelovanja
Pharmacotherapeutic group: antineoplastic agents, monoclonal antibodies, ATC code: L01XC16 Mechanism of action
Farmakoterapijska skupina: antineoplastici, monoklonska protutijela, ATK oznaka: L01XC16 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC22 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, monoklonska protutijela, ATK oznaka: L01XC22 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC24 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, monoklonska protutijela, ATK oznaka: L01XC24 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC27 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, monoklonska protutijela, ATK oznaka: L01XC27 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, other Antineoplastic agents, ATC code: L01XC19.
Farmakoterapijska skupina: Antineoplastični lijekovi – drugi antineoplastični lijekovi ATK oznaka: L01XC19.
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX05.
Farmakoterapijska skupina: Antineoplastične tvari, ostale antineoplastične tvari, ATK oznaka : L01XX05.
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX05.
Farmakoterapijska skupina: Antineoplastične tvari, ostale antineoplastične tvari, ATK oznaka: L01XX05.
Pharmacotherapeutic group: antineoplastic agents, other antineoplastic agents, ATC code: L01XX47
Farmakoterapijska skupina: antineoplastički lijekovi, drugi antineoplastički lijekovi, ATK oznaka: L01XX47
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX48 Mechanism of action
Farmakoterapijska skupina: antineoplastici, ostali antineoplastici, ATK oznaka: L01XX48 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, protein- kinase inhibitors, ATC code: L01XE11
Farmakoterapijska skupina: Antineoplastični lijekovi, inhibitori protein kinaze, ATK oznaka: L01XE11
Pharmacotherapeutic group: antineoplastic agents, plant alkaloids and other natural products,taxanes, ATC Code: L01CD02
Farmakoterapijska skupina: antineoplastici (citostatici), biljni alkaloidi, taksani, ATK oznaka: L01CD02.
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitor, ATC code: L01XE01 Mechanism of action
Farmakoterapijska skupina: antineoplastici, inhibitor protein-kinaze, ATK oznaka: L01XE01 Mehanizam djelovanja
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitor, ATC code: L01XE01 Mechanism of action
Farmakoterapijska skupina: ostali antineoplastici, inhibitori protein kinaze, ATK oznaka: L01XE01 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitor, ATC code: L01XE15 Mechanism of action and pharmacodynamic effects
Farmakoterapijska skupina: Antineoplastici, inhibitori protein-kinaze, ATK oznaka: L01XE15 Mehanizam djelovanja i farmakodinamički učinci
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitor, ATC code: L01XE23 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, inhibitori protein-kinaze, ATK oznaka: L01XE23 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitor, ATC code: L01XE25 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, inhibitori protein-kinaze, ATK oznaka: L01XE25 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitor; ATC Code: L01XE21
Farmakoterapijska skupina: antineoplastici, inhibitor protein-kinaze; ATK oznaka: L01XE21
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors, ATC code: L01XE18 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, inhibitori protein kinaze, ATK oznaka: L01XE18 Mehanizam djelovanja
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitors, ATC code: L01XE29 Mechanism of action
Farmakoterapijska skupina: antineoplastici, inhibitori protein-kinaze, ATK oznaka: L01XE29 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors.
Farmakoterapijska skupina: Antineoplastici, inhibitori protein-kinaze.
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitors; ATC code: L01XE02 Mechanism of action and pharmacodynamic effects
Farmakoterapijska skupina: Antineoplastici, inhibitori protein-kinaze; ATK oznaka: L01XE02 Mehanizam djelovanja i farmakodinamički učinci
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors; ATC code: L01XE04 Mechanism of action
Farmakoterapijska skupina: Antineoplastici, inhibitori protein-kinaze, ATK oznaka: L01XE04 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, pyrimidine analogues; ATC code: L01BC07 Mechanism of action
Farmakoterapijska skupina: antineoplastici, analozi pirimidina, ATK oznaka: L01BC07 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents, taxanes, ATC code: L01CD04 Mechanism of action
Farmakoterapijska skupina: antineoplastična sredstva, taksani; ATK oznaka: L01CD04 Mehanizam djelovanja
Pharmacotherapeutic group: Antineoplastic agents; Other antineoplastic agents ATC code: L01XX02
Farmakoterapijska skupina: antineoplastični lijekovi; drugi antineoplastični lijekovi ATK oznaka: L01XX02
Pharmacotherapeutic group: Antineoplastic and immunomodulating agents, other antineoplastic agents, ATC code: L01XX24
Farmakoterapijska skupina: Antineoplastici i imunomodulirajući lijekovi, ostala antineoplastici, ATK oznaka: L01XX24
Pharmacotherapeutic group: Antineoplastic and immunomodulating agents, other immunostimulants.
Farmakoterapijska grupa: Antineoplastični i imunomodulatorni lijekovi, drugi imunostimulansi.
Pharmacotherapeutic group: Antineoplastic and immunomodulating agents; immunostimulants; interferons ATC code: L03AB13
Farmakoterapijska skupina: Antineoplastici i imunomodulatori; imunostimulansi; interferoni, ATK oznaka: L03AB13
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents – endectocides.
Farmakoterapijska grupa: Antiparazitski proizvodi, insekticidi i repelenti - endektocidi.
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents, other ectoparasiticides for topical use, pyriproxyfen, combinations.
Farmakoterapijska grupa: antiparazitici, insekticidi i repelenti, ostali ektoparaziticidi za topikalnu primjenu, piriproksifen, kombinacije.
Pharmacotherapeutic group: antiparasitic products, insecticides, avermectins, eprinomectin in combinations.
Farmakoterapijska skupina: antiparazitarni proizvodi, insekticidi, avermektini, eprinomektin u kombinaciji.
Pharmacotherapeutic group: Antiprotozoals, antimalarials, artemisinin and derivatives, combinations, ATC code: P01BF05.
Farmakoterapijska skupina: antiprotozoici, antimalarici, artemizinin i derivati, kombinacije, ATK oznaka: P01BF05
Pharmacotherapeutic group: Antithrombotic agent (platelet aggregation inhibitors excl. heparin), ATC code: B01AC16
Farmakoterapijska skupina: Antitromboticki (inhibitor agregacije trombocita izuzev heparina), ATK oznaka: B01AC16
Pharmacotherapeutic group: Antithrombotic agent (platelet aggregation inhibitors excl. heparin), ATC code: B01AC16
Farmakoterapijska skupina: Antitrombotički agens (inhibitor agregacije trombocita izuzev heparina), ATK oznaka: B01AC16
Pharmacotherapeutic group: Antithrombotic agent (platelet aggregation inhibitors excl. heparin), ATC code: B01AC16
Farmakoterapijska skupina: Antitrombotički agens (inhibitori agregacije trombocita izuzev heparina), ATK oznaka: B01AC16
Pharmacotherapeutic group: antithrombotic agent, ATC Code: B01AD07 Mechanism of action
Farmakoterapijska skupina: antitrombotik, ATK oznaka: B01AD07 Mehanizam djelovanja
Pharmacotherapeutic group: Antithrombotic agents, ATC code: B01A D11 Mechanism of action
Farmakoterapijska skupina: Antitrombotici, ATK oznaka: B01A D11 Mehanizam djelovanja
Pharmacotherapeutic group: Antithrombotic agents, direct factor Xa inhibitors, ATC code: B01AF02 Mechanism of action
Farmakoterapijska skupina: antitrombotici, direktni inhibitori faktora Xa, ATK oznaka: B01AF02 Mehanizam djelovanja
Pharmacotherapeutic group: Antithrombotic agents, heparin group.
Farmakoterapijska skupina: : antitrombotici, heparinska skupina.
Pharmacotherapeutic group: Antithrombotic agents, heparin group.
Farmakoterapijska skupina: antitrombotici, heparinska skupina.
Pharmacotherapeutic group: Antithrombotic agents, heparin group.
Farmakoterapijska skupina: antitromboticii, heparinska skupina.
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC Code: B01AC-04.
Farmakoterapijska skupina:Antitrombotici, inhibitori agregacije trombocita izuzev heparina, ATK oznaka: B01AC04.
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excluding heparin, ATC code: B01AC11
Farmakoterapijska skupina: Antitrombotici, inhibitori agregacije trombocita izuzev heparina, ATK oznaka: B01AC11
Pharmacotherapeutic group: antithrombotic, direct thrombin inhibitors, ATC code: B01AE07.
Farmakoterapijska skupina: antitrombotik, direktni inhibitori trombina, ATK oznaka: B01AE07.
Pharmacotherapeutic group: antivirals for systemic use, antivirals for treatment of HIV infections, combinations; ATC code: J05AR03.
Farmakoterapijska skupina: antivirotici za sistemsku primjenu; antivirotici za liječenje HIV infekcije, kombinacije; ATK oznaka: J05AR03.
Pharmacotherapeutic group: Antivirals for systemic use, neuraminidase inhibitors ATC code: J05AH02
Farmakoterapijska skupina: Antivirotici za sustavnu primjenu, inhibitori neuraminidaze; ATK oznaka: J05AH02
Pharmacotherapeutic group: Antivirals for systemic use, neuraminidase inhibitors, ATC code: J05AH02
Farmakoterapijska skupina: Lijekovi za liječenje sustavnih virusnih infekcija, inhibitori neuraminidaze; ATK oznaka: J05AH02
Pharmacotherapeutic group: Antivirals for systemic use, non-nucleoside reverse transcriptase inhibitors, ATC code J05AG01.
Farmakoterapijska skupina: Antivirusni lijekovi za sistemsku primjenu, nenukleozidni inhibitori reverzne transkriptaze, ATK-oznaka J05AG01.
Pharmacotherapeutic group: antivirals for systemic use, nucleoside and nucleotide reverse transcriptase inhibitors, ATC code: J05AF04
Farmakoterapijska grupa: Antivirotici koji djeluju direktno, nukleozidni i nukleotidni inhibitori reverzne transkriptaze, ATK oznaka: J05AF04
Pharmacotherapeutic group: antivirals for systemic use, protease inhibitors, ATC code: J05AE12
Farmakoterapijska skupina: Lijekovi za sistemsko liječenje virusnih infekcija, inhibitori proteaze, ATK oznaka: J05AE12
Pharmacotherapeutic group: Antivirals for systemic use; antivirals for treatment of HIV infections, combinations, ATC code: J05AR16
Farmakoterapijska skupina: Pripravci za liječenje sustavnih virusnih infekcija, antivirotici za terapiju HIV-a, kombinacije, ATK oznaka: J05AR16.
Pharmacotherapeutic group: Antivirals for systemic use; Direct-acting antiviral, ATC code: J05AX68
Farmakoterapijska skupina: Antivirotici za sistemsku primjenu; Antivirotici koji djeluju direktno, ATK oznaka: J05AX68
Pharmacotherapeutic group: ATC code: D03BA03 bromelains
Farmakoterapijska skupina: ATK oznaka: D03BA03 bromelains
Pharmacotherapeutic group: Bacterial vaccines, ATC-code: J07AE01 Mechanism of action
Farmakoterapijska skupina: bakterijska cjepiva, ATK oznaka: J07AE01 Mehanizam djelovanja
Pharmacotherapeutic group: Beta-Blocking agent, non-selective, ATC code: C07AA05 Mechanism of action
Farmakoterapijska skupina: Beta-blokator, neselektivan, ATK oznaka: C07AA05 Mehanizam djelovanja
Pharmacotherapeutic group: Blood substitutes, ATCvet code: QB05AA90.
Farmakoterapijska grupa: Zamjene za plazmu, ATCvet kod: QB05AA90.
Pharmacotherapeutic group: Cardiac therapy, other cardiac preparations, ATC code: C01EB21 Mechanism of action
Farmakoterapijska skupina: Kardiološki lijekovi, ostali kardiološki pripravci, ATK oznaka: C01EB21 Mehanizam djelovanja
Pharmacotherapeutic group: Colony stimulating factors.
Farmakoterapijska grupa: faktor stimulacije kolonija.
Pharmacotherapeutic group: Corticosteroids for systemic use, glucocorticoids, ATC code: H02AB02 Mechanism of action
Farmakoterapijska skupina: kortikosteroidi za sistemsku primjenu, glukokortikoidi, ATK oznaka: H02AB02 Mehanizam djelovanja
Pharmacotherapeutic group: cytokines ATC code: L03AA02
Farmakoterapijska skupina: citokini, ATK oznaka: L03AA02
Pharmacotherapeutic group: cytokines, ATC code: L03AA02
Farmakoterapijska skupina: citokini, ATK oznaka: L03AA02
Pharmacotherapeutic group: decongestants and antiallergics; other antiallergics.
Farmakoterapijska skupina: dekongestivi i antialergici; ostali antialergici.
Pharmacotherapeutic group: Detoxifying agents for antineoplastic agents, ATC code: V03AF02 Two pharmacodynamic properties of dexrazoxane are described in the literature:
Farmakoterapijska skupina: detoksikacijske tvari za antineoplastične tvari, ATK oznaka: V03AF02 Dva farmakodinamička svojstva deksrazoksana su opisana u literaturi:
Pharmacotherapeutic group: Diagnostic radiopharmaceutical central nervous system, ATC code: V09AB03.
Farmakoterapijska grupa: Radiofarmaceutik za dijagnostiku središnjeg živčanog sustava, ATK oznaka: V09AB03.
Pharmacotherapeutic group: diagnostic radiopharmaceutical, central nervous system, ATC code: V09AX04
Farmakoterapijska skupina: dijagnostički radiofarmaceutik, središnji živčani sustav, ATC oznaka: V09AX04
Pharmacotherapeutic group: diagnostic radiopharmaceutical, tumour detection, ATC Code: V09IA09.
Farmakoterapijska skupina: dijagnostički radiofarmaceutik, otkrivanje tumora, ATC oznaka: V09IA09.